SS-31 (Elamipretide / Bendavia)
SS-31 (elamipretide) 10mg is a mitochondria-targeted tetrapeptide for in-vitro laboratory research into cardiolipin-associated inner-membrane biology. In-stock orders receive same-day dispatch from Victoria after payment confirmation, with tracked Australia Post Express shipping Australia-wide.
Elamipretide · mitochondria-targeted tetrapeptide research
SS-31 is a mitochondria-targeted tetrapeptide commonly called elamipretide; MTP-131 and Bendavia are further names used in the scientific literature. It is investigated in relation to cardiolipin-containing inner mitochondrial membranes and mitochondrial membrane biology. The product listing lists this product as SS-31 10mg for laboratory research. Buy SS-31 online in Australia from Australian-held inventory when stock is available, with dispatch from Victoria. This information distinguishes the named peptide, experimental research, the 10mg product listing and unavailable product-specific analytical records. It is supplied for in-vitro laboratory research only, not for human or animal use.
Also referred to in research or catalogue references as SS-31, SS31, elamipretide, MTP-131, Bendavia.
SS-31 is the research name commonly used for elamipretide, a synthetic tetrapeptide. The spellings SS31 and SS-31 identify the same named peptide. MTP-131 and Bendavia also occur in publications and development history. These names establish identity terminology only. They do not make products with different labels, manufacturing controls, excipients, analytical records or intended uses interchangeable.
Cardiolipin is an anionic phospholipid concentrated in the inner mitochondrial membrane. SS-31 research examines how the peptide associates with cardiolipin-containing membranes and how this may affect membrane organisation, cristae-related structure and bioenergetic processes. The proposed membrane-level context explains why SS-31 is studied in mitochondrial models. It is not evidence that this 10mg research product produces a clinical, performance, fatigue or longevity outcome.
A biophysical and computational study using model and mitochondrial membranes found that SS-31 partitioned into the membrane interfacial region and altered surface electrostatics and lipid-packing properties under its experimental conditions. The authors describe cardiolipin as important to SS-peptide activity in mitochondria, while also reporting that surface charge density, rather than one specific lipid identity, influenced binding. This is molecular and membrane research, not a demonstration of a health effect in people.
SS-31 is a synthetic tetrapeptide designed to target mitochondrial membranes. It is not the same molecule as MOTS-C, which is a mitochondrial-derived 16-amino-acid signalling peptide. Both may appear in mitochondrial research discussions, but their origins, structures, research questions and product documentation differ. A comparison link is provided for reference only and is not a recommendation to combine materials.
The preferred scientific source describes a mixed human-research record. It notes that several randomised elamipretide studies, including studies in heart failure and primary mitochondrial myopathy, did not meet their primary efficacy endpoints. Findings from a defined population, formulation, route, duration and endpoint cannot be transferred to a separate 10mg laboratory product. Preclinical membrane observations likewise do not establish a therapeutic use or a general human result.
In the United States, FORZINITY is a prescription elamipretide hydrochloride injection with a specific label, concentration, excipients, indication and manufacturer. Its active ingredient shares the elamipretide name, but this SS-31 10mg laboratory research product is not thereby the same finished medicine. Do not transfer the prescription label, clinical evidence, preparation details, sterility standards or handling directions of FORZINITY to this product.
The product listing records a 10mg product quantity. That figure is a mass listing, not a concentration, dose, administration amount or proof of biological activity. No final preparation volume is supplied for this product, so no concentration should be calculated or inferred. In laboratory work, any concentration depends on the material actually measured and a validated final volume; this page does not provide personal-use or reconstitution instructions.
No product-specific LabDoc report is currently published for this listing. Review available Quality/COA documentation; a report for another product does not verify this material.
SS-31 is commonly called elamipretide. SS31, MTP-131 and Bendavia are additional search or literature names for the same named peptide. They do not show that a research product is identical to a clinical formulation, prescription medicine or another supplier's material.
Researchers study SS-31 in connection with cardiolipin-containing inner mitochondrial membranes, membrane surface properties, cristae-related organisation and bioenergetic processes. Those are experimental research questions. They are not claims that this product treats mitochondrial disease, improves energy, enhances performance or changes ageing.
Elamipretide is the active ingredient named on the U.S. FORZINITY label, but the products are not interchangeable. FORZINITY is a specific prescription injection with its own concentration, ingredients, manufacturer, indication and regulatory label. None of those product-specific features or directions should be applied to this separate 10mg laboratory research product.
No. The product listing lists 10mg as the product quantity. It does not state a dose, schedule, liquid concentration or personal-use instruction. No final preparation volume is supplied, so a concentration cannot be inferred from the listed mass.
Yes, when stock is available. This laboratory research listing can be ordered online from Australian-held inventory, with dispatch from Victoria. Orders ship within Australia through Australia Post Express and tracking is provided after dispatch; delivery timing varies and is not guaranteed next day.
No product-specific LabDoc report is currently published for this listing. Review available Quality/COA documentation; a report for another product does not verify this material.
No product-specific LabDoc report is currently published for this listing. Review available Quality/COA documentation; a report for another product does not verify this material.
Scientific background reference
Scientific background is educational and separate from product-specific documentation. Neither establishes personal-use suitability or a clinical result for this research material.